Proyectos de ley › 89.ª Asamblea General
Relating to the decriminalization of certain schedule I controlled substances for the purposes of use by a patient diagnosed with a terminal illness or a life-threatening disease or condition
Temas:Health care
Dónde está ahora
- Hecho: Presentado11 de febrero de 2021
- Se detuvo: SubcomitéMurió al terminar la Asamblea General
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: Comité del Senado
- Sigue: Lo aprueba el Senado
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2022 terminó el 24 de mayo de 2022, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
La explicación oficial está en inglés; todavía no hay resumen en palabras sencillas.
This bill relates to the decriminalization of certain schedule I controlled substances for the purposes of use by a patient diagnosed with a terminal illness or a life-threatening disease or condition. Under the bill, the provisions of Code chapter 124 (controlled substances) including prohibited acts and penalties, do not apply to dimethyltryptamine (DMT); lysergic acid diethylamide (LSD); peyote; psilocybin; psilocyn; or MDMA when prescribed, possessed, handled, transported, delivered, or distributed by a health care provider or when possessed, handled, transported, or used by an eligible patient, in accordance with the bill.
Lea la explicación completa
Under the bill, an individual is an eligible patient if the individual has a terminal illness or a life-threatening disease or condition attested to by the individual’s treating health care provider; has considered and rejected or has tried and failed to respond to other treatment options approved by the United States food and drug administration; has received a recommendation from the individual’s treating health care provider for use of the controlled substance; has documentation from the individual’s treating health care provider that the individual meets these requirements; and has given written informed consent for the use of the controlled substance. The bill provides definitions for “eligible patient”, “health care provider”, “life-threatening disease or condition”, “terminal illness”, and “written informed consent”.